# GPT Healthcare Ltd (GPTHEALTH)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹140.65
Day Change: -0.89%
52W High: ₹184.8
52W Low: ₹114
Market Cap: ₹1,163 Cr

## Valuation
P/E: 28.67
P/B: 4.59
EPS: ₹4.94
Book Value: ₹30.87
Dividend Yield: 1.78%

## Returns
1Y Return: -2.76%

## Profitability
ROE: 0%
ROCE: 32.83%
Debt/Equity: 0.38
Revenue Growth: 17.6%
Profit Growth: -23.5%
EBITDA Margin: 15.46%
Operating Margin: 11.32%

## About
GPT Healthcare Ltd is a Medical Care Facilities company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Medical Care Facilities
Sub Industry: Unknown

## Business Model
Overview: GPT Healthcare Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Medical Care Facilities. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- Quarterly Report: Board Meeting Intimation for Approval Of Audited Results And Recommendation Of Final Dividend, If Any.
- BSE Filing: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

## Access
Current tier: anonymous
More history: Register free to see 3 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:02.224Z
Price History Updated: 2026-05-18T22:59:06.130Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:59:06.130Z
Quant Updated: 2026-05-18T22:59:06.130Z
Sentiment Updated: 2026-05-18T22:59:06.130Z
Financials Status: current
Financials Updated: 2026-05-19T02:30:54.068Z
Financials Last Attempt: 2026-05-19T02:30:54.068Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹406.45 Cr
Operating Profit: ₹67.12 Cr (OPM 16.51%)
Net Profit: ₹49.92 Cr
Tax: ₹19.42 Cr

## Annual P&L History
FY25: Rev ₹406.45Cr | PAT ₹49.92Cr | OPM 16.51%
FY24: Rev ₹399.55Cr | PAT ₹47.77Cr | OPM 18.04%
FY23: Rev ₹360.39Cr | PAT ₹39.01Cr | OPM 16.49%

## Balance Sheet (FY25)
Total Assets: ₹384.25 Cr
Total Liabilities: ₹136.4 Cr
Borrowings: ₹35.3 Cr
Cash: ₹1.66 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Om Prakash Tantia, Chairman & MD
- Ankur  Sharma, Company Secretary & Compliance Officer
- Anurag  Tantia, Executive Director
- Vishal  Goyal, Group Chief Operating Officer
- Sanjay Kant Mishra, Chief Operating Officer of ILS Salt Lake Hospital

---
Source: rupiya.io/stocks/gpthealth
Disclaimer: For research and education only. Not investment advice.